Refresh Lacri-Lube, Refresh P.M., FML 0.1 Percent and Blephamide 10 Percent/0.2 Percent by Allergan: Recall - Particulate Matter
Potential adverse events may include eye pain, eye sewelling, ocular discomfort or eye irritation.
Italiano
Potential adverse events may include eye pain, eye sewelling, ocular discomfort or eye irritation.
Severe allergic reactions, skin rashes, & cases of shingles (herpes zoster reactivation) reported. Severe eye injuries and skin reactions have occurred when Picato gel is not applied according to recommendations in the label.
Reports of internal flash fire when the OxyTOTE is mishandled or dropped.
Parenteral administration of non-sterile injection products may result in a site-specific or systemic infection, which in turn may cause hospitalization, significant morbidity, or a fatal outcome.
Preliminary information indicates that drugs stored in these syringes may lose potency over a period of time due to a possible interaction with the rubber stopper in the syringe.
Patients should consider having their mammograms re-evaluated at a certified facility.
L’Agenzia Italiana del Farmaco rende disponibili importanti informazioni
riguardo l’errore presente nel paragrafo 6 del Foglio Illustrativo di
alcuni lotti del medicinale “OXCARBAZEPINA TECNIGEN “ 600 mg
compresse”.
If this occurs, the tip could enter the patient’s bloodstream. This could cause serious injury to the patient and require additional medical intervention to retrieve the tip, or cause death.
Increased rate of pump thrombosis, high rate of stroke, bleeding complications.
Cases of PML in two patients with no prior exposure to immunosuppressant drugs.
80.211.154.110